vidarabine has been researched along with Extramembranous Glomerulopathy in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haller, NA; Lee, B; Novak, R; Robertson, S; Smith, RS; Tanphaichitr, N | 1 |
| Giannakakis, C; Guido, G; Mosillo, G; Rocca, AR; Salviani, C; Serriello, I | 1 |
| Manns, MP; Rambusch, EG | 1 |
| Asfoura, J; Butty, H; Cortese, F; Doyle, M; Rutecki, G | 1 |
| Austin, HA; Balow, JE; Boumpas, DT; Fleisher, TA; Kim, Y; Piscitelli, S; Pucino, F; Tassiulas, IO; Vaughan, E | 1 |
| Abdel-Raheem, MM; Gross, GG; Jamil, MG; Potti, A | 1 |
| Lin, CY; Lo, SC | 1 |
1 review(s) available for vidarabine and Extramembranous Glomerulopathy
| Article | Year |
|---|---|
Fludarabine in chronic lymphocytic leukemia with membranous nephropathy.
Topics: Aged; Antineoplastic Agents; Biopsy, Needle; Follow-Up Studies; Glomerulonephritis, Membranous; Humans; Immunohistochemistry; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Proteinuria; Rare Diseases; Risk Assessment; Treatment Outcome; Vidarabine | 2013 |
6 other study(ies) available for vidarabine and Extramembranous Glomerulopathy
| Article | Year |
|---|---|
Waldenström's macroglobulinemia and nephrotic syndrome with membranous nephropathy.
Topics: Adult; Angiotensin Receptor Antagonists; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Glomerulonephritis, Membranous; Humans; Immunoglobulin lambda-Chains; Immunoglobulin M; Male; Nephrotic Syndrome; Rituximab; Vidarabine; Waldenstrom Macroglobulinemia | 2011 |
[Therapy of hepatitis C-associated extrahepatic diseases].
Topics: Antiviral Agents; Combined Modality Therapy; Cryoglobulinemia; Glomerulonephritis, Membranous; Hepatitis C; Humans; Vidarabine | 1998 |
Chronic lymphocytic leukemia-associated membranous glomerulopathy: remission with fludarabine.
Topics: Antineoplastic Agents; Biopsy; Female; Glomerulonephritis, Membranous; Humans; Kidney; Leukemia, Lymphocytic, Chronic, B-Cell; Vidarabine | 1999 |
A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
Topics: Adult; Alkylating Agents; Anti-Inflammatory Agents; B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Humans; Immunoglobulin G; Immunologic Memory; Immunosuppressive Agents; Lupus Nephritis; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Pilot Projects; Prednisone; Proteinuria; Renal Plasma Flow, Effective; Sinusitis; Vidarabine | 1999 |
Fludarabine therapy in chronic lymphocytic leukemia-associated severe nephrotic syndrome.
Topics: Antineoplastic Agents; Diagnosis, Differential; Female; Glomerulonephritis, Membranous; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Nephrotic Syndrome; Proteinuria; Remission Induction; Treatment Outcome; Vidarabine | 2000 |
Treatment of hepatitis B virus-associated membranous nephropathy with adenine arabinoside and thymic extract.
Topics: Adjuvants, Immunologic; B-Lymphocytes; Child; DNA, Viral; Glomerulonephritis, Membranous; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Macrophages; T-Lymphocytes; Thymus Extracts; Vidarabine | 1991 |